Breaking News, Collaborations & Alliances

ImmuneRegen, Azopharma in Homspera Pact

Azopharma will perform research services to further develop ImmuneRegen's lead drug candidate Homspera

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc., has entered a strategic partnership agreement with Azopharma Product Development Group. Azopharma will perform research services to further develop ImmuneRegen’s lead drug candidate Homspera. Azopharma will provide full development services to ImmuneRegen, including drug manufacturing, formulation development, and such preclinical services as IND-enabling toxicology and safety pharmacology studies...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters